Home / Shop / Anti Cancer / UJVIRA 100 MG

UJVIRA 100 MG

₹20,500.00 ₹34,728.75 Save ₹14,228.75
Ujvira 100mg Injection contains Trastuzumab emtansine, a monoclonal antibody used primarily to treat HER2-positive cancers, such as breast cancers.
Treatment decisions involving Trastuzumab emtansine are closely tied to the disease settings recorded here: HER2-positive breast cancer, including residual invasive disease after neoadjuvant therapy and metastatic disease after prior HER2-directed therapy. HER2 antibody delivers a maytansinoid microtubule inhibitor (DM1) to HER2-expressing cells. HER2 biology is central to treatment selection, and the clinical role depends on the tumor's HER2 status and disease setting. It is categorized as Targeted Therapy; Antibody-Drug Conjugate; HER2-Directed Therapy, with Breast Cancer listed as the principal tumor types. The regimen field includes T-DM1 monotherapy; adjuvant T-DM1 after neoadjuvant therapy with residual disease. Those combinations are clinically meaningful because the same medicine can have a different role when paired with endocrine therapy, chemotherapy, another targeted agent, or supportive treatment. Molecular and disease-specific eligibility can therefore be more important than tumor location alone when the treatment is considered. For clinicians reviewing the database, the drug name should therefore be interpreted together with histology, stage, prior therapy, and the relevant biomarker or eligibility requirement. Its pharmacologic class provides useful context, but does not replace disease-specific selection criteria. The wording is intended as a reference synthesis rather than a prescribing protocol and deliberately avoids individualized dose recommendations. Oncology approvals and guideline-supported uses can change over time, so contemporary labeling remains important.
Therapy Category Targeted Therapy, Antibody-Drug Conjugate, Her2-Directed Therapy
Protocols/Regimens T-Dm1 Monotherapy, Adjuvant T-Dm1 After Neoadjuvant Therapy With Residual Disease
Primary Indications Her2-Positive Breast Cancer, Including Residual Invasive Disease After Neoadjuvant Therapy And Metastatic Disease After Prior Her2-Directed Therapy
Cancer/Tumor Types Breast Cancer
Salt / Active Composition UJVIRA TRASTUZUMAB EMTANSINE
Strength / Dosage 100
Dosage Form Injection
Prescription Required Yes

Complete Your Order

UJVIRA 100 MG
UJVIRA 100 MG

₹20,500.00 × 1 = ₹20,500.00

Accepted formats: PDF, JPG, PNG (Max 5MB)
Added to cart successfully!

Book Your Consultation Now

×

✔ 15+ Years of Surgical Experience

✔ All Insurances Accepted

Cancer Medicine

My Cart

0 items
100% Genuine Cold-Chain Verified Express Delivery

Saved Medicines